Ethypharm is a European-based speciality pharmaceutical company with global reach and is a committed player in the treatment of pain, addiction and critical care.
Ethypharm develops, manufactures and supplies cost effective complex medicines that allows better access to medicines for patients across the world.
Our ambition is to grow our own commercial structures in Europe and to accelerate our global expansion through strong and sustainable partnerships. We are actively seeking new value-adding products in our fields of expertise.
We have a strong presence and expertise in marketing hospital and speciality medicines and we are recognised as a key strategic partner and a trusted provider of quality and affordable medicines to the NHS and other healthcare providers.
Focusing on the treatment of pain, addiction and critical care, Ethypharm in the UK develops, manufactures and commercialises value-adding drugs at our two manufacturing sites that specialise in the development and production of sterile injectables and oral liquids.
In 2017 Ethypharm Group acquired Martindale Pharma, a leading UK based specialty pharmaceutical company which provides essential medicines to the UK and other global markets. By joining forces with Martindale Pharma, Ethypharm reinforced its presence in the UK. The combined business reaches a broader geographical footprint and enhances manufacturing capabilities to include solid dose, injectables and oral liquids.